Assessment and rehabilitation of cognitive impairment in multiple sclerosis

References

• Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Archives of Neurology 2001; 58: 1602–1606
   PubMed Web of Science ®Google Scholar
• Amato MP, Zipoli V, Portaccio E. Multiple sclerosis related cognitive changes: A review of cross-sectional and longitudinal studies. Journal of the Neurological Sciences 2006; 245: 41–46
   PubMed Web of Science ®Google Scholar
• Audoin B, Ibarrola D, Ranjeva JP, Confort-Gouny S, Malikova I, Ali-Chérif A, et al. Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Human Brain Mapping 2003; 20: 51–58
   PubMed Web of Science ®Google Scholar
• Baddeley A. Working memory. Science 1992; 255: 556–559
   PubMed Web of Science ®Google Scholar
• Barak Y, Achiron A. Effect of interferon beta 1-b on cognitive functions in multiple sclerosis. European Neurology 2002; 47: 11–14
   PubMed Web of Science ®Google Scholar
• Beatty WW, Goodkin DE. Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination. Archives of Neurology 1990; 47: 297–301
   PubMed Web of Science ®Google Scholar
• Beatty WW, Goretti B, Siracusa G, Zipoli V, Portaccio E, Amato MP, et al. Changes in neuropsychological test performance over the workday in multiple sclerosis. Clinical Neuropsychology 2003; 17: 551–560
   PubMed Web of Science ®Google Scholar
• Benedict RHB. Integrating cognitive function screening and assessment into the routine care of multiple sclerosis patients. CNS Spectrum 2005; 10: 384–391
   PubMed Web of Science ®Google Scholar
• Benedict RH, et al. Scales and methods to measure cognition. Proceedings of the MS forum Modern Management Workshop. Budapest 2008a; 28–33
   Google Scholar
• Benedict RHB, Cookfair D, Gavett R, Gunther R, Munschauer F, Garg N, et al. Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). Journal of the International Neuropsychological Society 2006; 12: 549–558
   PubMed Web of Science ®Google Scholar
• Benedict RHB, Fischer JS, Archibald CJ, Annett PA, Beatty WW, Bobholz J, et al. Minimal neuropsychological assessment of MS patients: A consensus approach. Clinical Neuropsychologist 2002; 16: 381–397
   PubMed Web of Science ®Google Scholar
• Benedict RHB, Munschauer F, Linn R, et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Multiple Sclerosis 2003; 9: 95–101
   PubMed Web of Science ®Google Scholar
• Benedict RH, Munschauer F, Zarevics P, Erlanger D, Rowe V, Feaster T, et al. Effects of l-amphetamine sulphate on cognitive function in multiple sclerosis patients. Journal of Neurology 2008b; 255: 848–852
   PubMed Web of Science ®Google Scholar
• Benedict RHB, Shapiro A, Priore R, Miller C, Munschauer F, Jacobs L. Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients. Multiple Sclerosis 2000; 6: 391–396
   PubMed Web of Science ®Google Scholar
• Benedict RHB, Zivadinov R. Reliability and validity of neuropsychological screening and assessment strategies in MS. Journal of Neurology 2007; 254: 22–25
   Google Scholar
• Bobholz JA, Rao SM. Cognitive dysfunction in multiple sclerosis: A review of recent developments. Current Opinion in Neurology 2003; 16: 283–288
   PubMed Web of Science ®Google Scholar
• Calabrese P. Neuropsychology of multiple sclerosis: An overview. Journal of Neurology 2006; 253: 10–15
   PubMed Web of Science ®Google Scholar
• Charcot JM. Lectures on the diseases of the nervous system. New Sydenham Society, London 1877
   Google Scholar
• Christodoulou C, Melville P, Scherl WF, Macallister WS, Elkins LE, Krupp LB, et al. Effects of donepezil on memory and cognition in multiple sclerosis. Journal of the Neurological Sciences 2006; 245: 127–136
   PubMed Web of Science ®Google Scholar
• Compston A, Coles A. Multiple sclerosis. Lancet 2002; 359: 1221–1231
   PubMed Web of Science ®Google Scholar
• Demaree HA, Gaudino E, DeLuca J. The relationship between depressive symptoms and cognitive dysfunction in multiple sclerosis. Cognitive Neuropsychiatry 2003; 8: 161–171
   PubMedGoogle Scholar
• Denney DR, Sworowski LA, Lynch SG. Cognitive impairment in three subtypes of multiple sclerosis. Archives of Clinical Neuropsychology 2005; 20: 967–981
   PubMed Web of Science ®Google Scholar
• Doraiswamy PM, Rao SM. Treating cognitive deficits in multiple sclerosis: Are we there yet?. Neurology 2004; 63: 1552–1553
   PubMedGoogle Scholar
• Engel C, Greim B, Zettl UK. Diagnostics of cognitive dysfunction in multiple sclerosis. Journal of Neurology 2007; 254: 30–34
   Google Scholar
• Feinstein A. The neuropsychiatry of multiple sclerosis. Canadian Journal of Psychiatry 2004; 49: 157–163
   PubMed Web of Science ®Google Scholar
• Feinstein A. Mood disorders in multiple sclerosis and the effects on cognition. Journal of the Neurological Sciences 2006; 245: 63–66
   PubMed Web of Science ®Google Scholar
• Fischer JS. Assessment of neuropsychological function. Multiple Sclerosis Therapeutics, RA Rudick, JA Cohen. Martin Dunitz, London 2002
   Google Scholar
• Fischer JS, Priore RL, Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, et al. Neuropsychological effects of interferon beta 1-b in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Annals of Neurology 2000; 48: 885–892
   PubMed Web of Science ®Google Scholar
• Flacheneker P, Kumpfel T, Kallman B, Cottschalk M, Grauer O, Rieckmann P, et al. Fatigue in multiple sclerosis: A comparison of different rating scales and correlation to clinical parameters. Multiple Sclerosis 2002; 8: 523–526
   PubMedGoogle Scholar
• Fowley FW, Dince WM, Bedell NG, LaRocca NG, Kalb R, Caruso LS, et al. Psychoremediation of communication skills for cognitively impaired persons with multiple sclerosis. Journal of Neurological Rehabilitation 1994; 8: 165–176
   Google Scholar
• Freedman MS, (2006). Disease-modifying drugs for multiple sclerosis: Current and future aspects. Expert Opinion in Pharmacotherapy, 7, S1-S9
   Google Scholar
• Gerschlager W, Beisteiner R, Deecke L, Dirnberger G, Endi W, Kolleger H, et al. Electrophysical, neuropsychological and clinical findings in multiple sclerosis patients receiving interferon beta-1b: A one-year follow-up. European Neurology 2000; 44: 205–209
   PubMedGoogle Scholar
• Ghaffar O, Feinstein A. The neuropsychiatry of multiple sclerosis: A review of recent developments. Current Opinion in Psychiatry 2007; 20: 278–285
   PubMed Web of Science ®Google Scholar
• Haase CG, Tinnefeld M, Lienemann M, Ganz RE, Faustmann PM. Depression and cognitive impairment in disability free early multiple sclerosis. Behavioral Neurology 2003; 14: 39–45
   PubMed Web of Science ®Google Scholar
• Henry JD, Beatty WW. Verbal fluency deficits in multiple sclerosis. Neuropsychologia 2006; 44: 1166–1174
   PubMed Web of Science ®Google Scholar
• Herman MA, Jick SS, Logroscino MJ, Olek MJ, Ascherio A, Jick H. Cigarette smoking and the progression of multiple sclerosis. Brain 2005; 128: 1461–1465
   PubMedGoogle Scholar
• Hoffman S, Tittgemeyer M, Yves von Cramon D. Cognitive impairment in multiple sclerosis. Current Opinion in Neurology 2007; 20: 275–280
   PubMed Web of Science ®Google Scholar
• Huijbregts SCJ, Kalkers NF, de Sonneville LMJ, de Groot., Polman CH. Cognitive impairment and decline in different MS subtypes. Journal of the Neurological Sciences 2006; 24: 187–194
   Google Scholar
• Huijbregts SCJ, Kalkers NF, de Sonneville LMJ, de Groot V, Reuling IEW, Polman CH, et al. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology 2004; 63: 335–339
   PubMed Web of Science ®Google Scholar
• Jonsson A, Korfitzen EM, Heltberg A, Ravnborg MH, Byskon-Ottosen E. Effects of neuropsychological treatment in patients with multiple sclerosis. Acta Neurologica Scandinavia 1993; 88: 394–400
   PubMed Web of Science ®Google Scholar
• Kappos L, Freedman MS, Polman CH, et al. Effect of early versus delayed interferon beta 1-b treatment on disability after a first clinical event suggestive of multiple sclerosis: A three-year follow-up analysis of the BENEFIT study. Lancet 2007; 370: 389–397
   PubMed Web of Science ®Google Scholar
• Krupp LB, Christodoulou C, Melville P, Scherl WF, MacAllister WS, Elkins LE, et al. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 2004; 63: 1579–1585
   PubMed Web of Science ®Google Scholar
• Krupp IB, Elkins LE. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 2000; 55: 934–939
   PubMed Web of Science ®Google Scholar
• Lazeron RH, Boringa JB, Schouten M, et al. Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis. Multiple Sclerosis 2005; 11: 524–531
   PubMed Web of Science ®Google Scholar
• Litvan J, Grafman J, Vendrell P, Martinez JM, Junque C, Vendrell JM, et al. Multiple memory deficits in patients with multiple sclerosis: Exploring the working memory system. Archives of Neurology 1988; 45: 607–610
   PubMed Web of Science ®Google Scholar
• Lovera J, Bagert B, Smoot K, Morris CD, Frank R, Bogardus K, et al. Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: A randomized, placebo-controlled trial. Multiple Sclerosis 2007; 13: 376–387
   PubMed Web of Science ®Google Scholar
• Lynch SG, Parmenter BA, Denney DR. The association between cognitive impairment and physical disability in multiple sclerosis. Multiple Sclerosis 2005; 11: 469–476
   PubMed Web of Science ®Google Scholar
• Mahler ME, Benson DF. Cognitive dysfunction in multiple sclerosis: A subcortical dementia?. Neurobehavioral aspects of multiple sclerosis, SM Rao. Oxford University Press, New York 1990; 88–101
   Google Scholar
• McKhann GM. Multiple sclerosis. Annual Review of Neuroscience 1982; 5: 219–239
   PubMed Web of Science ®Google Scholar
• Messinis L, Anyfantis E, Paschali A, Papathanasopoulos P. Neuropsychological deficits in relapsing remitting multiple sclerosis patients with low disability status. Proceedings of the 7th International Congress on the Improvement of the Quality of life on Dementia, Parkinson's disease, Epilepsy, MS, Muscular disorders and Neuroethics, Thessaloniki, January, 2009, (in press)
   Google Scholar
• Nocentini U, Pasqualetti P, Bonavita S, Buccafuscam M, De Caro MF, Farina D, et al. Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis 2006; 12: 77–87
   PubMed Web of Science ®Google Scholar
• Olivares T, Nieto A, Sanchez MP, Wollman T, Hernandez MA, Barroso J, et al. Pattern of neuropsychological impairment in the early phase of relapsing-remitting multiple sclerosis. Multiple Sclerosis 2005; 11: 191–197
   PubMed Web of Science ®Google Scholar
• Oliveri RL, Sibilia G, Valentino P, Russo C, Romeo N, Quattrone A. Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis. Acta Neurologica Scandinavia 1998; 97: 366–369
   PubMedGoogle Scholar
• Ozakbas S, Idiman E, Kaya D, Poyraz T, Poyraz E. Effects of mitoxantrone treatment on cognitive and physical disability in patients with multiple sclerosis. Neurology 2008; 70: SP02.117
   Google Scholar
• Parry AM, Scott RB, Palace J, Smith S, Mathews PM. Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine. Brain 2003; 126: 2750–2760
   PubMed Web of Science ®Google Scholar
• Patti F. Cognitive impairment in multiple sclerosis. Multiple Sclerosis 2009; 15: 2–8
   PubMed Web of Science ®Google Scholar
• Paulesu E, Frith CD, Frackowiak RSJ. The neural correlates of the verbal component of working memory. Nature 1993; 362: 342–344
   PubMed Web of Science ®Google Scholar
• Pelosi L, Geesken JM, Holly M, Hayward M, Blunkhart LD. Working memory impairment in early multiple sclerosis: Evidence from an event-related potential study of patients with clinically isolated myelopathy. Brain 1997; 120: 2039–2058
   PubMed Web of Science ®Google Scholar
• Peterson JW, Bo L, Mork S, Chang A, Trapp BD. Transected neuritis, apoptic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Annals of Neurology 2001; 50: 389–400
   PubMed Web of Science ®Google Scholar
• Penner IK, Kappos L. Retraining attention in MS. Journal of the Neurological Sciences 2006; 245: 147–151
   PubMedGoogle Scholar
• Pierson SH, Griffith N. Treatment of cognitive impairment in multiple sclerosis. Behavioural Neurology 2006; 17: 53–67
   PubMed Web of Science ®Google Scholar
• Pliskin NH, Hamer DP, Goldstein DS, Towler VL, Reder AT, Noronha A, et al. Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology 1996; 47: 1463–1468
   PubMed Web of Science ®Google Scholar
• Plohman AM, Kappos L, Ammann W, THordai A, Wittwer A, Huber S, et al. Computer assisted retraining of attentional impairments in patients with multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1998; 64, 455–462
   Google Scholar
• Potagas C, Giogkaraki E, Koutsis G, Mandelos D, Tsirempolou E, Sfagos C, et al. Cognitive impairment in different MS subtypes and clinically isolated syndromes. Journal of the Neurological Sciences 2008; 267: 100–106
   PubMed Web of Science ®Google Scholar
• Portaccio E, Goretti B, Zipoli G, Siracusa S, Amato MP. A short version of Rao's brief repeatable battery as a screening tool for cognitive impairment in multiple sclerosis. Clinical Neuropsychologist 2009; 23: 268–275
   PubMed Web of Science ®Google Scholar
• Randolph JJ, Arnett PA, Higginson CL. Metamemory and tested cognitive functioning in multiple sclerosis. Clinical Neuropsychologist 2001; 15: 357–368
   PubMed Web of Science ®Google Scholar
• Rao SM. Neuropsychology of multiple sclerosis: A critical review. Journal of Clinical and Experimental Neuropsychology 1986; 8: 503–542
   PubMed Web of Science ®Google Scholar
• Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991a; 41: 685–691
   PubMed Web of Science ®Google Scholar
• Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991b; 41: 692–696
   PubMed Web of Science ®Google Scholar
• Rao SM. Neuropsychology of multiple sclerosis. Current Opinion in Neurology 1995; 8: 216–220
   PubMed Web of Science ®Google Scholar
• Rocca MA, Falini A, Colombo B, Rossi P, Comi G, Filippi M, et al. Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage. Annals of Neurology 2002; 51: 330–339
   PubMed Web of Science ®Google Scholar
• Rogers JM, Panegyres PK. Cognitive impairment in multiple sclerosis: Evidence-based analysis and recommendations. Journal of Clinical Neurosciences 2007; 14: 919–927
   PubMed Web of Science ®Google Scholar
• Rovaris M, Filippi M, Falautano L, et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998; 50: 1601–1608
   PubMed Web of Science ®Google Scholar
• Ruggieri RM, Palermo R, Vitello G, Gennusco M, Settipani N, Piccoli F. Cognitive impairment in patients suffering from relapsimg-remitting multiple sclerosis with EDSS <3.5. Acta Neurologica Scandinavia 2003; 108: 323–326
   PubMed Web of Science ®Google Scholar
• Sartori E, Edan G. Assessment of cognitive dysfunction in multiple sclerosis. Journal of Neurological Sciences 2006; 245: 169–175
   PubMed Web of Science ®Google Scholar
• Schwid SR, Tyler CM, Scheid EA, Weinstein A, Goodman AD, McDermott MP, et al. Cognitive fatigue during a test requiring sustained attention: A pilot study. Multiple Sclerosis 2003; 9: 503–508
   PubMed Web of Science ®Google Scholar
• Schwid SR, Goodman AD, Weinstein A, McDermott MP, Johnson KP. Cognitive function in relapsing remitting multiple sclerosis: Minimal changes in a 10-year clinical trial. Journal of the Neurological Sciences 2007; 255: 57–63
   PubMed Web of Science ®Google Scholar
• Schulz D, Kopp B, Kunkel A, Faiss JH. Cognition in the early stages of multiple sclerosis. Journal of Neurology 2006; 253: 1002–1010
   PubMed Web of Science ®Google Scholar
• Sohlberg MM, Mateer CA. Cognitive Rehabilitation: An integrative neuropsychological approach. Guilford Press, New York 2001
   Google Scholar
• Staffen WA, Mair H, Zauner A, Unterrainer J, Niederhofer H, Kuttzeluigg A, et al. Cognitive function and fMRI in patients with multiple sclerosis: Evidence for compensatory cortical activation during an attention task. Brain 2002; 125: 1275–1282
   PubMed Web of Science ®Google Scholar
• Strober LB, Englert JJ, Alt M, Munschauer F, Weinstock-Guttman B, Benedict RH, et al. Comparing the sensitivity of memory tests in multiple sclerosis (MS): The Rao Brief Repeatable Neuropsychological Battery (BRNB) and the Minimal Assessment of Cognitive Function in MS (MACFIMS). Journal of the International Neuropsychological Society, 36th Annual Meeting, February 6–9, Waikoloa, Hawaii, 2008, Abstract
   Google Scholar
• Weinstein A, Scwid SR, Schiffer RB, McDermott MP, Giang DW, Goodman AD, et al. Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Archives of Neurology 1999; 56: 319–324
   PubMed Web of Science ®Google Scholar
• Vogt A, Kappos L, Calabrese P, Stocklin MN, Geschwind L, Opwis K, et al. Working memory training in patients with multiple sclerosis – Comparison of two different training schedules. Restorative Neurology and Neurosciences 2009; 27: 225–235
   PubMed Web of Science ®Google Scholar
• Zakzanis KK. Distinct neurocognitive profiles in multiple sclerosis subtypes. Archives of Clinical Neuropsychology 2000; 15: 115–136
   PubMed Web of Science ®Google Scholar
• Zephir H, de Seze J, Dujardin K, Dubois G, Cabaret M, Bouillauet S, et al. One year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis. Multiple Sclerosis 2005; 11: 360–363
   PubMed Web of Science ®Google Scholar
• Zivadinov VR, De Masi D, Nasuelli LM, Monti Bragadin L, Ukmar M, Pozzi Mucceli RS, et al. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis. Neuroradiology 2001; 43: 272–278
   PubMed Web of Science ®Google Scholar